Animal Blood Product Market, By Product Type (Whole Blood, Plasma, Serum, Red Blood Cells, Platelets, White Blood Cells, and Other Blood Derivatives), By End User (Pharmaceutical Companies, Academic and Research Institutes, Veterinary Clinics, Diagnostic

The global animal blood products market has emerged as a vital component of the animal healthcare industry, playing a crucial role in the treatment and prevention of various diseases in livestock and companion animals. Animal blood products, derived from the blood of healthy animals, are used in a wide range of applications, including immunization, disease diagnosis, and therapy. The market has witnessed significant growth in recent years, driven by factors such as increasing demand for animal protein, rising pet ownership, and advancements in veterinary medicine. As the world population continues to grow and the demand for animal-derived products surges, the animal blood products market is expected to expand further, presenting numerous opportunities for stakeholders in the industry.

Market Dynamics:

The global animal blood products market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing demand for animal protein, fueled by population growth and changing dietary preferences. As the consumption of meat, dairy, and other animal-derived products rises, the need for effective animal healthcare solutions, including blood products, grows in tandem. Additionally, the rising trend of pet ownership and the growing emphasis on pet health and wellness contribute to the market's growth. However, the market also faces certain restraints, such as concerns over the safety and efficacy of animal blood products, stringent regulatory requirements, and ethical considerations surrounding animal welfare. Despite these challenges, the market presents significant opportunities for growth, including the development of innovative and advanced blood products, the expansion of veterinary healthcare infrastructure in emerging economies, and the increasing adoption of companion animals in households worldwide. As the animal healthcare industry continues to evolve and address the changing needs of livestock and pets, the animal blood products market is poised for further growth and development.

Key Features of the Study:

• This report provides in-depth analysis of the global animal blood products market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global animal blood products market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Neogen Corporation, VetBiotek, Hemostatix, BioProducts Laboratory Ltd, Vetoquinol, Grifols S.A., Luitpold Pharmaceuticals, Zoetis Inc., IDEXX Laboratories Inc., Parnell Pharmaceuticals, Elanco Animal Health, Merck Animal Health, Cegelec, Virbac, and Pfizer Animal Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global animal blood products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal blood products market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• Whole Blood
• Plasma
• Serum
• Red Blood Cells
• Platelets
• White Blood Cells
• Other Blood Derivatives (e.g., immunoglobulins, fibrinogen, serum albumin)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
• Pharmaceutical Companies
• Academic and Research Institutes
• Veterinary Clinics
• Diagnostic Laboratories
• Blood Transfusion Services
• Others (Academic and Research Institutions)
• Source Animal Insights (Revenue, USD Bn, 2020 - 2032)
• Bovine
• Porcine
• Equine
• Canine
• Feline
• Others
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
• Online
• Offline
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Neogen Corporation
• VetBiotek
• Hemostatix
• BioProducts Laboratory Ltd
• Vetoquinol
• Grifols S.A.
• Luitpold Pharmaceuticals
• Zoetis Inc.
• IDEXX Laboratories Inc.
• Parnell Pharmaceuticals
• Elanco Animal Health
• Merck Animal Health
• Cegelec
• Virbac
• Pfizer Animal Health

Show more